102 On the other hand, quite a few groups are advocating with the incorporation of novel markers, such as a advanced karyotype55 or epigenetic subsets, 27,28 into scientific follow. All these novel prognostic and/or predictive types will need to be validated in cohorts of patients dealt with with fo